These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 176457)

  • 1. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
    Yajima Y; Tanaka A; Nonoyama M
    Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Epstein-Barr virus DNA in vitro: effects of phosphonoacetic acid, N-ethylmaleimide, and ATP.
    Seebeck T; Shaw JE; Pagano JS
    J Virol; 1977 Jan; 21(1):435-8. PubMed ID: 189079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
    Patel P; Menezes J
    Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition by phosphonoacetic acid of MDV DNA replication in a lymphoblastoid cell line.
    Nazerian K; Lee LF
    Virology; 1976 Oct; 74(1):188-93. PubMed ID: 185787
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis.
    Feighny RJ; Henry BE; Pagano JS
    J Virol; 1981 Jan; 37(1):61-71. PubMed ID: 6261001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid.
    Thorley-Lawson D; Strominger JL
    Nature; 1976 Sep; 263(5575):332-4. PubMed ID: 183149
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 16. The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.
    Decaussin G; Leclerc V; Ooka T
    J Virol; 1995 Nov; 69(11):7309-14. PubMed ID: 7474160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
    Casareale D; Jones W; Sairenji T; Humphreys RE
    Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.
    Lin JC
    Antiviral Res; 2003 Jun; 59(1):41-7. PubMed ID: 12834859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid.
    Huang ES
    J Virol; 1975 Dec; 16(6):1560-5. PubMed ID: 172657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.